Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Avexitide's Phase 3 Success Boosts Amylyx (NASDAQ: AMLX) Shares Significantly

Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) achieved a significant milestone as it reported a 63.84% increase in shares, closing at $35.11, following strong phase 3 clinical trial results for its hypoglycemia treatment Avexitide. The stock jumped as high as $35.39 during intraday trading, marking a …

Vinay Lochav | 20 August 2026

EDAP TMS S.A. (NASDAQ: FOCL): FocalTherics Reports Q2 2026 Revenue Growth of 39% to $13.2M

This performance not only exceeded analysts' expectations but also highlights the accelerating adoption of its robotic focal therapy solutions, driven by a 47% growth in U.S. procedure volumes. This rapid growth reflects a thriving market for non-invasive treatment options, underscoring FocalTherics' strategic initiative to …

Vinay Lochav | 20 August 2026

Jaguar Health (NASDAQ: JAGX) Reports Q2 2026 Results, Highlights Mytesi Performance

Jaguar Health, Inc. (NASDAQ: JAGX) has released its second-quarter results for 2026, showcasing the performance of its primary product, Mytesi. The report, issued on August 19, highlights the effectiveness of Mytesi in managing noninfectious diarrhea among adult patients undergoing antiretroviral therapy for HIV/AIDS. The …

Vinay Lochav | 20 August 2026

New Executive Appointments at Organigram Following Sanity Group Integration

Organigram has executed a strategic integration of Sanity Group into its global operations while appointing a series of new executives. This significant move enhances the company’s management infrastructure, aimed at ensuring an efficient alignment between both entities. Analysts suggest that the integration reflects Organigram's …

Vinay Lochav | 20 August 2026

Analysts Upgrade Healthcare Stock to Buy, Boosting Market Sentiment

Market Sentiment Shifts with Healthcare Upgrade

Vinay Lochav | 20 August 2026

Functional Brands Inc. (NASDAQ: MEHA) Reports $1.87M in Q2 2026 Revenue, Up 2%

This growth was attributed to strongDemandthrough its direct-to-consumer sales channel and increased contractManufacturingactivity. Despite this positive development, the company’s broader financial environment remains challenging, as it continues to face market pressures and elevated operational costs. The increase in revenue showcases the potential for continued …

Vinay Lochav | 20 August 2026

Apple and Samsung Gain Ground as Chip Prices Rise in India

Market Dynamics Shifting Amid Rising Chip Costs

Vinay Lochav | 20 August 2026

Broadcom Faces Pressure as Marvell Secures Google Partnership

Broadcom faces increasing competition after Marvell has partnered with Google for critical semiconductor supply. This development could significantly impact Broadcom'sMarket Shareand investor confidence, as analysts adjust outlooks based on reshaped alliances within the tech industry.Key HighlightsMarvell has secured a lucrativePartnershipwith Google, impacting Broadcom's position …

Vinay Lochav | 20 August 2026

King Tide to Boost NuRAN Wireless Investor Engagement

NuRAN Wireless has officially engaged King Tide as its new partner for investor relations services, a strategic move aimed at enhancing investor communication and better engaging with stakeholders. This initiative is significant given the increasing importance of transparent communication in building trust with investors. …

Vinay Lochav | 20 August 2026

OpenAI Plans IPO by 2027, CFO Assures Employees Amid Competition

OpenAI will become a public company by 2027, as confirmed by CFO Sarah Friar. This announcement alleviates concerns among employees about competitive pressures from rival Anthropic, marking a critical step in OpenAI's growth and market presence.Key HighlightsCFO Sarah Friar assured employees during an all-hands …

Vinay Lochav | 20 August 2026
Support

Hi! How can we help you today?

Loading…